Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study

Published:2018-03-26 Issue:11 Volume:124 Page:2316-2326
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gill Harinder¹,Yim Rita¹,Lee Harold K. K.²,Mak Vivien²,Lin Shek-Ying³,Kho Bonnie⁴,Yip Sze-Fai⁵,Lau June S. M.⁶,Li Wah⁷,Ip Ho-Wan⁸,Hwang Yu-Yan¹,Chan Thomas S. Y.¹,Tse Eric¹,Au Wing-Yan⁹,Kumana Cyrus R.¹,Kwong Yok-Lam¹^ORCID

Affiliation:

1. Department of Medicine; Queen Mary Hospital; Hong Kong China

2. Department of Medicine; Princess Margaret Hospital; Hong Kong China

3. Department of Medicine; United Christian Hospital; Hong Kong China

4. Department of Medicine; Pamela Youde Eastern Hospital; Hong Kong China

5. Department of Medicine; Tuen Mun Hospital; Hong Kong China

6. Department of Medicine; Queen Elizabeth Hospital; Hong Kong China

7. Department of Clinical Oncology; Prince of Wales Hospital; Hong Kong China

8. Department of Pathology; Queen Mary Hospital; Hong Kong China

9. Blood-Med Clinic; Hong Kong China.

Funder

Seed Funding for Basic Research

University of Hong Kong

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. How I treat acute promyelocytic leukemia;Tallman;Blood.,2009

2. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol;Tallman;Blood.,2002

3. High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG;Lengfelder;Leukemia.,2009

4. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group;Lo-Coco;Blood.,2010

5. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience;Kelaidi;J Clin Oncol.,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2024-09-04

2. Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?;Expert Review of Hematology;2024-08-12

3. Realgar-indigo naturalis formula for the treatment of patients with relapsed and arsenic trioxide-resistant acute promyelocytic leukemia: A case series;Journal of Integrative Medicine;2024-08

4. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-Analysis;Transplantation and Cellular Therapy;2024-06

5. Indigo production goes green: a review on opportunities and challenges of fermentative production;World Journal of Microbiology and Biotechnology;2024-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3